Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06577909 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy

Study acronym: IVIg
StatusUnknown
PhasePhase 2
Started2023-10-19
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 29, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
minor
Trial status changed: Recruiting → Unknown
This is a prospective, randomized, open-label, multicenter clinical trial study to compare the efficacy and safety of prednisone plus IVIg to prednisone monotherapy in the treatment of immune thrombocytopenia (ITP) in pregnancy.
Trial Details
NCT Number NCT06577909
Lead Sponsor Peking University People's Hospital
Conditions Immune Thrombocytopenia
Enrollment 100 participants
Start Date 2023-10-19
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-29